Neogen Corp (NEOG)

This is a pharmaceutical company/ biotechnology company that has been very consistent at growing the business without going out on a limb too far. They have make aquisitions and integrated them nicely into the company.

Fortune 40

President Obama's creation of a new Food Safety Working Group and key FDA appointments, is willing to spend over a billion dollars to overhaul the industry and promises tougher food safety measures to protect the public from future bungles in the system such as the recent peanut butter debacle.

NEOG has no debt, positive cashflow, low float, share buyback, and average quarterly earnings growth (year over year) of approximately 19.9%, boosted by their acquisitions.

Going forward, this small cap stock has a favorable outlook for 2009.

Solid little company, probably will be assimilated into some big corporate Borg eventually. Only worries are that they have to survive in the Michigan political/economic climate and they are in a field where it's so easy to get badly tangled up in lawsuits if anything goes wrong.

can't go wrong with food safety in future

ibd

Neogen is a well managed company that flys just under the radar of most Wall Street analysts. The analysts tend to follow IDEXX Labs as a proxy for this sector. I like Neogen here for its smaller size and flexibility. The company carries no debt and has healthy insider ownership. It also produces consistent results quarter to quarter and rarely disappoints.

Neogen has two separate, but related businesses. The first has to do with food safety testing for both humans and animals. This is obviously an area that has constant demand. The demand will accelerate as globalization makes it more difficult to follow food-borne disease. I wouldn't be surprised if the next administration beefs up the regulatory oversight responsibilities of the FDA and gets more serious about food safety, given recent panics over salmonella and such.

The second business involves the development and manufacture of a whole range of veteranary medicines and treatments. This is where Neogen unviels its biotech roots, but compounds and drugs developed for animals are approved much more easily than those for humans. I like the companies positioning, management, and balance sheet. Definitely a long term outperformer.

Jumping Back In

who doesn't love a puppy or kitten?

Recession proof industry!
Pretty good PE ratio! Go for it

Member of the "Penny Stock Posse."

bling bling

Small risk, but food safety will be important to people.

Should see long term gain.

Lab diagnostics-you just can't go wrong here-relatively recession proof

This animal and fodd safety products company is settling down after have a great run from mid 06 to the fall of 07. I lexpect this stock to take continue its upward move within the next couple months.

Testing out a portfolio of smallish-cap 5-star stocks found using the CAPS screener. All picks have at least 50 allstars backing them, which should be enough to minimize star rating fluctuations. It's been less than a week, but so far so good!

A solid company with good management; good execution over time.

Long term winner

Solid company that is buying "bolt on" companies that expand the product line with a minimum of additional investment, which helps the company increase it's revenue and profits very steadily.